期刊文献+

血清肿瘤标志物检测在贲门癌及胃窦癌诊断中的应用价值 被引量:6

Application value of serum tumor markers in the diagnosis of cardiac and gastric carcinoma
下载PDF
导出
摘要 目的 比较血清肿瘤标志物联合检测在贲门癌及胃窦癌诊断中阳性率的差异,探讨其临床应用价值. 方法 选择2010-12 ~2014-03就诊于我院并且资料完整的212例胃癌患者进行研究,根据其癌症部位分为胃窦癌组和贲门癌组,并以200例健康体检病人作为正常对照组进行分析.比较三种血清肿瘤标志物血清癌胚抗原(CEA)、糖类抗原72-4(CA72-4)以及糖类抗原19-9(CA19-9)单独检测以及联合检测对贲门癌及胃窦癌诊断阳性率的影响. 结果 单独检测3种肿瘤标志物对贲门癌和胃窦癌的阳性率经统计学分析差异无统计学意义(P>0.05);而联合肿瘤标志物进行检测时,CA72-4联合CA19-9检测对其阳性率影响不大(P>0.05),但CEA的联合检测阳性率明显提高,胃窦癌组三者联合检测的阳性率可高达72.90%,而贲门癌组三者联合检测的阳性率也可达58.10%,差异有统计学意义(P<0.05). 结论 血清CEA、CA72-4以及CA19-9水平在贲门癌及胃窦癌的诊断上具有一定的临床意义,联合检测可显著提高胃癌尤其是胃窦癌的诊断阳性率,其结果优于单独检测,值得在临床上推广使用. Objective To compare the difference of serum tumor markers in the diagnosis of cardia cancer and gastric antrum cancer, and to explore its clinical application value. Methods A total of 212 cases of gastric cancer with complete clinical information from December 2010 to March 2014 in our hospital were chosen in this study, and they were divided into gastric cancer group and cardia cancer group according to the cancer site. Another 200 cases of healthy subjects were chosen as control group. The positive rate of sin- gle or combined detection of serum carcinoembryonie antigen( CEA), carbohydrate antigen 72-4 (CA72-4 ) and carbohydrate antigen 19- 9 ( CA19- 9) among three groups was compared. Results There was no statistical difference in the positive rate of single detec- tion of three tumor markers for cardia cancer and gastric antrum cancer( P 〉 0.05 ). The combined detection of CA72-4 and CA19-9 had no significant difference in the diagnosis of cardia cancer and gastric antrum cancer (P 〉 0.05 ), while the positive rate of combined detection with CEA was improved. The positive rate of combined detection of three markers was 72.90% for gastric antrum cancer and 58.10% for cardiac cancer( P 〈 0.05 ). Conclusion Serum CEA, CA72-4 and CA19-9 levels have certain clinical significance in the diagnosis of gastric cardia cancer and gastric antrum cancer, and the combined detection can significantly improve the positive diag- nosis rate of gastric cancer, especially the gastric antrum cancer,which is better than the single detection and worthy of clinical applica- tion.
出处 《山西医科大学学报》 CAS 2014年第10期950-952,共3页 Journal of Shanxi Medical University
关键词 贲门癌 胃窦癌 癌胚抗原 糖类抗原 cardia cancer gastric antrum cancer carcinoembryonic antigen carbohydrate antigen
  • 相关文献

参考文献14

  • 1邹雄.肿瘤标志在肿瘤早期诊断中的研究与应用进展[J].中华检验医学杂志,2002,25(2):71-72. 被引量:97
  • 2孙秀娣,牧人,周有尚,戴旭东,张思维,皇甫小梅,孙杰,李连弟,鲁凤珠,乔友林.中国胃癌死亡率20年变化情况分析及其发展趋势预测[J].中华肿瘤杂志,2004,26(1):4-9. 被引量:701
  • 3杨达伟.血清肿瘤标志物谱及趋化因子蛋白谱提高肺癌早期诊断及预后预测的临床研究[D].复旦大学,2012.
  • 4邱毅,陈炼,曾彤琴,刘毅菊.联合检测血清胃癌肿瘤标志物的临床应用[J].浙江临床医学,2008,10(3):412-413. 被引量:15
  • 5王秀芹,马宏星,严惟力.肿瘤标志物联合检测对消化系统肿瘤的诊断价值[J].标记免疫分析与临床,2010,17(2):83-86. 被引量:21
  • 6Leung WK,Wu MS,Kakugawa Y,et al.Screening for gastric cancer in Asia:current evidence and practice[J].Lancet Oncol,2008,9(3):279-287.
  • 7Ohtsu A,Yoshida S,Saijo N.Disparities in gastric cancer chemotherapy between the East and West[J].Clin Oncol,2006,24(14):2188-2196.
  • 8郭成业,闫春,于文军,等.联合检测血清CA72-4,CA19-9,CEA对胃癌临床价值的探讨[J].中国临床肿瘤杂志,2007,27(11):776-777.
  • 9Dilege E,Mihmanli M,Demir U,et al.Prognostic value of preoperatire CEA and CA19-9 levels in resectable gastric cancer[J].Hepatogastroenterology,2010,57 (99-100):674-677.
  • 10Lukaszewicz-Zajae M,Mroczko B,Gryko M,et al.Comparison between clinical significance of seillm proinflammatory proteins(IL-6 and CRP) and classic tumor markers(CEA and CA19-9) in gastric cancer[J].Clin Exp Med,2011,11(2):89-96.

二级参考文献56

共引文献846

同被引文献60

  • 1张建斌.上消化道气钡双重造影胃窦变形的X线分析[J].延安大学学报(医学科学版),2010,8(3):61-62. 被引量:2
  • 2隋金环.浅析急性胃炎的诊断和治疗[J].中外健康文摘,2011,08(05).
  • 3杨达伟.血清肿瘤标志物谱及趋化因子蛋白谱提高肺癌早期诊断及预后预测的临床研究[D].复旦大学,2012.
  • 4Cidón E U,Bustamante R.Gastric cancer:tumor markers as predictive factors for preoperative staging[J].J Gastrointest Cancer,2011,42(3):127.
  • 5Kim D H,Oh S J,Oh C A,et al.The relationships between perioperative CEA,CA19-9,and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy[J].J Surg Oncol,2011,104(6):585.
  • 6Woo Y,Hyung W J,Obama K,et al.Elevated high-sensitivity C-reactive protein,a marker of advanced stage gastric cancer and postgastrectomy disease recurrence[J].J Surg Oncol,2011,Epub ahead of print.
  • 7Mroczko B,Lukaszewicz-Zajc M,Gryko M,et al.Clinical significance of serum levels of matrix metalloproteinase 2(MMP-2)and its tissue inhibitor(TIMP-2)in gastric cancer[J].Folia Histochem Cytobiol,2011,49(1):125.
  • 8Fan B,Xiong B.Investigation of serum tumor markers in the diagnosis of gastric cancer[J].Hepatogastroenterology,2011,58(105):239.
  • 9Schauer M,Peiper M,Theisen J,et al.Prognostic factors in patients with diffuse type gastric cancer(linitis plastica)after operative treatment[J].Eur J Med Res,2011,16(1):29.
  • 10Dilege E,Mihmanli M,Demir U,et al.Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer[J].Hepatogastroenterology,2010,57(99-100):674.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部